Analyst Ratings for Harmony Biosciences Holdings Inc. (HRMY)
HRMY Rating Summary
HRMY Price Target Summary
- Highest: $62.00 (Oppenheimer)
- Lowest: $25.00 (Truist Securities)
- Average: $41.56
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$41.56 (+46.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/23/2026 | Deutsche Bank | David Hoang | Downgrade | Hold (Buy) |
31.00 (47.00) |
29.16 (28.33) |
-2.85% | Details |
| 2/20/2026 | Truist Securities » Updated 2/24/2026 |
Danielle Brill | Downgrade | Hold (Buy) |
25.00 (N/A) |
34.39 (28.33) |
-17.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
